Matchday SAT 21 NOV

UFC

Avoiding errors in the UFC anti-doping policy

USADA implements specific thresholds for atypical findings to protect athletes from trace contaminants in substances like SARMS and GW-1516. The policy also mandates strict TUE criteria and testing requirements, such as the six-month pool requirement for veterans returning to competition.

Avoiding errors in the UFC anti-doping policy

Thresholds and atypical findings

The updated policy provides necessary protections for athletes against trace contaminants but imposes rigid barriers for returning veterans. The new policy allows fighters to compete while USADA investigates findings for eight specific substances. If a drug concentration falls below certain levels, USADA classifies the result as an "atypical finding" rather than an automatic violation. This policy prevents fighters from facing immediate sanctions for trace amounts of contaminants in supplements. USADA still maintains the authority to sanction athletes if they prove the fighter intentionally used a substance or recklessly disregarded an obvious risk. Fighters often misinterpret these specific limits.

Substance Threshold for Atypical Finding
DHCMT (M3) 0.1 ng/mL
SARMS 0.1 ng/mL
GW-1516 0.1 ng/mL
Epitrenbolone 0.2 ng/mL
HCTZ/Torsemide 20 ng/mL (Out-of-Competition)

While these thresholds exist, USADA still investigates cases to see if an athlete intentionally used a prohibited substance. The program specifically targets substances such as GW1516, Clomiphene, and Selective Androgen Receptor Modulators (SARMS). For street drugs like marijuana and cocaine, the in-competition window lasts from six hours before the weigh-in until six hours after the event. This window prevents fighters from facing penalties for trace amounts found outside that timeframe.

TUE application requirements

Athletes must prove four strict criteria to obtain a Therapeutic Use Exemption (TUE) for a banned medication. They must show that a legitimate medical condition requires treatment, no reasonable non-prohibited alternative exists, the treatment provides no significant performance enhancement, and they did not use the substance without a TUE previously. USADA’s TUEC panel of three medical experts reviews these applications. One athlete recently saw her appeal denied by the American Arbitration Association after she claimed she required DHEA to treat adrenal fatigue, a condition the TUEC does not recognize as a credible medical diagnosis. You should check the exact definition of your medical condition before applying to ensure it meets ISTUE requirements.

The TUE process demands extensive documentation. Athletes must demonstrate that their medical need satisfies all four strict ISTUE Article 4.1 criteria. TUEs provide specific dosage, route of administration, and period of time, but they expire. USADA also provides a drug reference hotline called Drug Reference Online to assist with these needs. WADA maintains the right to monitor and reverse any TUE decision made by an organization like USADA.

Testing and returning athletes

Three missed tests within a 12-month period constitute a violation of the UFC anti-doping policy. Conor McGregor accepted an 18-month ineligibility period after missing biological sample collections on June 13, September 19, and September 20, 2024. His sanction remains retroactive to the date of his third missed test, September 20, 2024. This penalty decreased from the standard 24 months because he cooperated with the inquiry and was recovering from an injury during the missed collections. Fighters face different requirements based on how they left the organization. Fighters who left the UFC of their long-term training contracts or of their own accord must remain in the USADA testing pool for six months before they compete again, whereas newcomers or those released by the promotion only face a one-month requirement.

The policy aims to stop fighters from using banned substances while retired and returning quickly. The in-competition window starts at noon the day before the fight and closes upon post-fight sample collection. If a sample collection does not occur within a reasonable time, the window closes one hour after the fighter receives medical clearance. Does the six-month requirement for voluntary departures create an unfair barrier for veteran fighters?

Back to top